Clinical Trials Browser

INDUSTRY × Neoplasms × vadimezan × Clear all

NCT01299415 2011-09-02

Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor

Phase 1 Terminated

Neoplasms

NCT00856336 2009-03-05

DART

Phase 1 Completed

Neoplasms